Anticancer efficacy in vivo and in vitro, synergy with 5-fluorouracil, and safety of recombinant methioninase

Cancer Research

Volumn 58, Issue 12, 1998, Pages 2583-2587

  Yoshioka, Takayuki ^a   Wada, Tohru ^a   Uchida, Naomi ^a   Maki, Hideo ^a   Yoshida, Hiroshi ^a   Ide, Nobuyuki ^a   Kasai, Hisanori ^a   Hojo, Kanji ^a   Shono, Kimiyo ^a   Maekawa, Ryuji ^a   Yagi, Shigeo ^a   Hoffman, Robert M ^b   Sugita, Kenji ^a  

^a SHIONOGI AND CO LTD   (Japan)

^b ANTICANCER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; METHIONINE; METHIONINE GAMMA LYASE; RECOMBINANT METHIONINE GAMMA LYASE; UNCLASSIFIED DRUG;

ANEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENTIATION; FEMALE; HUMAN; HUMAN CELL; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LEWIS CARCINOMA; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; CARBON-SULFUR LYASES; CARCINOMA, LEWIS LUNG; DRUG SYNERGISM; FEMALE; FLUOROURACIL; HUMANS; METHIONINE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; SURVIVAL ANALYSIS; TUMOR CELLS, CULTURED;

EID: 17544399144     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Hoffman, R. M., and Erbe, R. W. High in vivo rates of methionine biosynthesis in transformed human and malignant rat cells auxotrophic for methionine. Proc. Natl. Acad. Sci. USA, 73: 1523-1527, 1976.
2. Kreis, W., and Goodenow, M. Methionine requirement and replacement by homocysteine in tissue cultures of selected rodent and human malignant and normal cells. Cancer Res., 38: 2259-2262, 1978.
3. Mecham, J. O., Rowitch, D., Wallace, C. D., Stern, P. H., and Hoffman, R. M. The metabolic defect of methionine dependence occurs frequently in human tumor cell lines. Biochem. Biophys. Res. Commun., 117: 429-434, 1983.
4. Hoffman, R. M. Altered methionine metabolism, DNA methylation, and oncogene expression in carcinogenesis: a review and synthesis. Biochim. Biophys. Acta, 738: 49-87, 1984.
5. Guo, H., Herrera, H., Groce, A., and Hoffman, R. M. Expression of the biochemical defect of methionine dependence in fresh patient tumors in primary histoculture. Cancer Res., 53: 2479-2483, 1993.
6. Breillout, F., Antoine, E., and Poupon, M. F. Methionine dependency of malignant tumors: a possible approach for therapy. J. Natl. Cancer Inst., 82: 1628-1632, 1990.
7. Goseki, N., Yamazaki, S., Endo, M., Onodera, T., Kosaki, G., Hibino, Y., and Kuwahata, T. Antitumor effect of methionine-depleting total parenteral nutrition with doxorubicin administration on Yoshida sarcoma-bearing rats. Cancer (Phila.), 69: 1865-1872, 1992.
8. Hoshiya, Y., Guo, H., Kubota, T., Inada, T., Asanuma, F., Yamada, Y., Koh, J., Kitajima, M., and Hoffman, R. M. Human tumors are methionine dependent in vivo. Anticancer Res., 15: 717-718, 1995.
9. Guo, H., Tan, Y., Kubota, T., Moossa, A. R., and Hoffman, R. M. Methionine depletion modulates the antitumor and antimetastatic efficacy of ethionine. Anticancer Res., 16: 2719-2724, 1996.
10. Lishko, V. K., Lishko, O. V., and Hoffman, R. M. The preparation of endotoxin-free-L-methionine-α-deamino-γ-mercaptomethane-lyase (L-methioninase) from Pseudomonas putida. Protein Expression Purif., 4: 529-533, 1993.
11. Lishko, V. K., Lishko, O. V., and Hoffman, R. M. Depletion of serum methionine by methioninase in mice. Anticancer Res., 13: 1465-1468, 1993.
12. Tan, Y., Xu, M., Guo, H., Sun, X., Kubota, T., and Hoffman, R. M. Anticancer efficacy of methioninase in vivo. Anticancer Res., 16: 3931-3936, 1996.
13. Tan, Y., Zavala, J., Sr., Xu, M., Zavala, J., Jr., and Hoffman, R. M. Serum methionine depletion without side effects by methioninase in metastatic breast cancer patients Anticancer Res., 16: 3937-3942, 1996.
14. Tan, Y., Zavala, J., Sr., Han, Q., Xu, M., Sun, X., Tan, X-Z., Tan, X-Y., Magana, R., Geller, J., and Hoffman, R. M. Recombinant methioninase infusion reduces the biochemical endpoint of serum methionine with minimal toxicity in high-stage cancer patients. Anticancer Res., 17: 3857-3860, 1997.
15. Tan, Y., Xu, M., Tan, X. Z., Tan, X., Wang, X., Saikawa, S., Nagahama, T., Sun, X., Lenz, M., and Hoffman, R. M. Overexpression and large-scale production of recombinant L-methionine-α-deamino-γ-mercaptomethane-lyase for novel anticancer therapy. Protein Expression Purif., 9: 233-245, 1997.
16. Inoue, H., Inagaki, K., Sugimoto, M., Esaki, N., Soda, K., and Tanaka, H. Structual analysis of the L-methionine-γ-lyase from Pseudomonas putida. J. Biochem. (Tokyo), 117: 1120-1125, 1995.
17. Hori, H., Takabayashi, K., Orvis, L., Carson, D. A., and Nobori, T. Gene cloning and characterization of Pseudomonas putida L-methionine-α-deamino-γ-mercaptomethane-lyase. Cancer Res., 56: 2116-2122, 1996.
18. Guo, H., Lishko, V. K., Herrera, H., Groce, A., Kubota, T., and Hoffman, R. M. Therapeutic tumor-specific cell cycle block induced by methionine starvation in vivo. Cancer Res., 53: 5676-5679, 1993.
19. Hoffman, R. M., and Jacobsen, S. J. Reversible growth arrest in SV40-transformed human fibroblasts. Proc. Natl. Acad. Sci. USA, 77: 7306-7310, 1980.
20. 6 methylguanine DNA methyltransferase by methionine in human tumor cells. Br. J. Cancer, 75; 779-788, 1997.
21. Kokkinakis, D. M., Schold, S. C., Jr., Hori, H., and Nobori, T. Effect of long term depletion of plasma methionine on the growth and survival of human brain tumor xenografts in athymic mice. Nutr. Cancer, 29: 195-204, 1997.
22. Scanlon, K. J., Newman, E. M., Lu, Y., and Priest, D. G. Biochemical bases for cisplatm and 5-fluorouracil synergism in human ovarian carcinoma cells. Proc. Natl. Acad. Sci. USA, 83: 8923-8925, 1986.
23. Goseki, N., Yamazaki, S., Shimojyu, K., Kando, F., Maruyama, M., Endo, M., Koike, M., and Takahashi, H. Synergistic effect of methionine depleting total parenteral nutrition with 5-fluorouracil on human gastric cancer: a randomized, prospective clinical trial. Jpn. J. Cancer Res., 86: 484-489, 1995.
24. Tanaka, H., Esaki, N., and Soda, K. Properties of L-methionine-γ-lyase from Pseudo-monas ovalis. Biochemistry, 16: 100-106, 1977.
25. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein using the principle protein-dye binding. Anal. Biochem., 72: 248-254, 1976.
26. Alley, M. C., Scudiero, D. A., Monks, A., Hursey, M. L., Czerwinski, M. J., Fine, D. L., Abott, B. J., Mayo, J. G., Shoemaker, R. H., and Boyd, M. R. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res., 48: 589-601, 1988.
27. Yancopoulos, G. D., and Alt, F. W. Preparation of DNA and RNA. In: A. Bothwell, G. D. Yancopoulos, and F. W. Alt (eds.), Methods for Cloning and Analysis of Eukaryotic Genes, pp. 4-5. Boston: Jones and Bartlett Publishers, 1990.
28. Heinrikson, R. L., and Meredith, S. C. Amino acid analysis by reverse phase high-performance liquid chromatography: precolumn derivatization with phenylisothiocyanate. Anal. Biochem., 136: 65-74, 1984.
29. Koenuma, M., Kasai, H., Uchida, N., Wada, T., Hattori, M., Oguma, T., Totani, T., and Inaba, M. Pharmacokinetic correlation between experimental and clinical effects on human non-small cell lung cancers of cis-diammineglycolatoplatinum (254-S) and cis-diamminedichloroplatinum. Anticancer Res., 15: 417-422, 1995.
30. Uchida, N., Kasai, H., Takeda, Y., Maekawa, R., Sugita, K., and Yoshioka, T. Synergy of the combination of Nedaplatin with Etoposide in murine and human lung carcinoma. Anticancer Res., 18: 247-252, 1998.
31. Dunnet, C. W. New tables for multiple comparisons with a control. Biometrics, 20: 482-491, 1964.
32. Gavrieli, Y., Sherman, Y., and Ben-Sasson, S. A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol., 119: 493-501, 1992.
33. Machover, D., Goldschmidt, E., Chollet, P., Metzger, G., Zittoun, J., Marquet, J., Vandenbulcke, J. M., Misset, J. L., Schwarzenberg, L., and Fourtillan, J. B. Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid. J. Clin. Oncol., 4: 685-696, 1986.
34. Holland, J. F., Frei, M., III, Pizzorno, G., Cheng, Y. C., and Handschumacher, R. E. (eds.). Pyrimidine and purine antimetabolites. In: Cancer Medicine, pp. 925-928. Baltimore: Williams & Wilkins, 1997.
35. Lowe, S. W., Ruley, H. B., Jacks, T., and Houseman, D. E. p53 dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell, 74: 957-967, 1993.
36. Lowe, S. W., Bodis, S., McClatchey, A., Remington, L., Ruley, H. E., Fisher, D. E., Houseman, D. E., and Jacks, T. p53 status and the efficacy of cancer therapy in vivo. Science (Washington DC), 266: 807-810, 1994.
37. 1 arrest in human cancer cells. Cancer Res., 55: 5187-5190, 1995.
38. Rodrigues, N. R., Rowan, A., Smith, M. E., Kerr, I. B., Bodmer, W. F., Gannon, J. V., and Lane, D. P. p53 mutations in colorectal cancer. Proc. Natl. Acad. Sci. USA, 87: 7555-7559, 1990.